On participating whole life, the honest answer is frequently that surrendering beats selling, and you can determine which side of the line you are on with two numbers. The first is your current cash surrender value, which the carrier will tell you in one phone call. The second is the insured’s realistic life expectancy. Everything else is detail. A buyer’s offer has to exceed what you could get by simply asking the company for the money, and on a mature whole life contract that hurdle is high.
The crossover is driven almost entirely by life expectancy. At a twelve-year estimate, discounting a distant death benefit against twelve years of a fixed premium that a buyer cannot reduce usually produces a number below the surrender value. At a five-year estimate, the same policy can be worth substantially more to a buyer than to the company’s surrender department. This page walks through those numbers, then covers the tax difference between the two routes, which is larger than most people expect and which sometimes flips the answer on its own.
In This Article
- Get the surrender value first; it sets the floor
- The buyer’s math and where the crossover sits
- Your policy may be worth more than the schedule page says
- Surrender and sale are taxed differently, and the gap is not small
- The middle options, which usually win
- The company, the regulator, and what to send
- Frequently Asked Questions
Get the surrender value first; it sets the floor
Call the carrier and request a current in-force values statement. Ask for five figures specifically: the base face amount; the total death benefit including any paid-up additions; the total cash surrender value as of today; the current annual dividend; and your cost basis, meaning total premiums paid, if the company tracks it.
That last item matters for tax and most people never ask for it. Companies do not always have complete premium histories on very old contracts, in which case you or your accountant will need to reconstruct it from records. Start now rather than at the point of decision.
The surrender value is the floor under every alternative because it is available unconditionally. No medical review, no buyer, no underwriting, no waiting for offers, no rescission period, no counterparty risk. Anything else on the table has to beat it by enough to justify a process that takes months and exposes the insured’s medical file to third parties. See what cash surrender value is and how surrender value compares to an offer.
One caution on the phone call: ask for the value net of any outstanding policy loan. Loans reduce both the surrender value and the death benefit, and an owner who has borrowed over the years is sometimes surprised by how much the net figure has moved.
The buyer’s math and where the crossover sits
A buyer estimates a life expectancy from medical records, projects the premiums required to hold the policy across that horizon, discounts the death benefit back at a target rate of return, and subtracts projected premiums and transaction costs. What is left is the offer.
Two features of whole life work against that calculation. The premium is fixed and scheduled and cannot be reduced. On a universal life chassis a buyer minimum-funds the contract, paying only what keeps it alive; on whole life it must pay the contractual premium, which is designed to endow the policy rather than merely sustain it. And your surrender value is high, which raises the bar the offer must clear.
The table below shows the shape of the crossover using a $250,000 policy with a $110,000 surrender value and a $6,000 annual premium. The figures are illustrative rather than quotes, and real offers vary between buyers because independent life expectancy estimates frequently differ by years. But the direction is reliable: at long life expectancies surrender wins comfortably, and at short life expectancies a sale can win by a wide margin.
Which means the decision is mostly a medical question, not a financial one. If the insured is in reasonable health for their age, expect surrender to win and do not spend three months finding out. If the insured has a significant impairment with documented treatment history, the calculation is genuinely open and worth running properly. See surrender versus sell.
Your policy may be worth more than the schedule page says
OneAmerica’s principal insurer, American United Life Insurance Company, sits within a mutual holding company structure, which means participating policies share in divisible surplus through a dividend. On an older contract, that dividend has usually been doing something for decades, and what it has been doing changes the numbers materially.
The most common election is to purchase paid-up additions: each annual dividend buys a small block of permanent, fully paid coverage that itself earns dividends in later years. Compounded across thirty or forty years, the total death benefit and total cash value can both sit well above the base face amount printed on the schedule page. The other standard options are to take the dividend in cash, apply it to reduce the premium, leave it to accumulate at interest, or use it to buy one-year term coverage.
Ask two more questions while you have someone on the phone. First, how is the dividend currently being applied, and can it be redirected? Redirecting a mature dividend to reduce or cover the premium is the single most effective response to an affordability problem on this product, and it requires no medical review. Second, if your policy originated with Pioneer Mutual Life Insurance Company of Fargo, North Dakota, which affiliated with American United Life in 1997, ask how dividends are determined for that block today.
Dividends are not guaranteed. They depend on the company’s mortality, expense and investment experience, and a declining dividend scale reduces future additions and can cause a premium-offset arrangement to require premiums again later. Ask for projections at both the current scale and a reduced scale. See how participating whole life works.
| Life expectancy estimate | Years of premium a buyer must fund | Illustrative gross value to a buyer | Your surrender value | Which route wins |
|---|---|---|---|---|
| 15 years | 15 x $6,000 | Well below surrender value | $110,000 | Surrender, clearly |
| 12 years | 12 x $6,000 | Below surrender value | $110,000 | Surrender |
| 8 years | 8 x $6,000 | Approaching surrender value | $110,000 | Close; worth running properly |
| 5 years | 5 x $6,000 | Meaningfully above surrender value | $110,000 | A sale can win |
| 3 years or terminal | 3 x $6,000 | Substantially above surrender value | $110,000 | Sale, and check viatical tax treatment |
Surrender and sale are taxed differently, and the gap is not small
This is general information about how the rules operate, not advice for your situation, and the numbers depend on facts only your accountant can see. But the framework matters enough to state.
On a surrender, the taxable amount is generally the cash surrender value received minus your cost basis, which is broadly the premiums you paid. That gain is generally treated as ordinary income. If there is an outstanding loan, the loan is treated as an amount received, which is how owners end up with a taxable gain larger than the cash they actually collect.
On a sale, the framework the IRS set out in Revenue Rulings 2009-13 and 2009-14 governs the structure of the calculation, and Congress changed one input in the 2017 tax act. Before that change, an owner’s basis had to be reduced by the cost of insurance charges absorbed over the life of the policy, which increased the taxable gain on a sale. The 2017 legislation eliminated that basis reduction for sale transactions, so basis is now generally premiums paid without that subtraction. The practical effect is that the same policy can produce a smaller taxable gain on a sale than the pre-2017 rules would have produced.
Settlement transactions also carry information reporting. Reportable policy sales trigger reporting under Internal Revenue Code section 6050Y, with final regulations issued in 2019, and the parties involved issue forms to the seller and to the insurer. Expect paperwork, and expect your accountant to want it.
Separately, if the insured is terminally or chronically ill within the meaning of the viatical settlement rules in section 101(g), proceeds may be excluded from income entirely, which can change the comparison dramatically. Do not assume it applies; the definitions are specific and require certification. Read how tax basis works in a settlement and whether proceeds are taxable, then take both to your own tax professional.
The middle options, which usually win
Most people arrive at this question because a premium has become difficult, not because they want to liquidate an asset. If that describes you, four options sit between keeping and unwinding, and one of them almost always fits.
- Premium offset. Redirect the dividend, sometimes together with the surrender of accumulated paid-up additions, to cover the premium. On a mature contract this can make the policy effectively self-paying. Not guaranteed, so ask for projections at a reduced dividend scale as well.
- Partial surrender of paid-up additions. Additions can often be surrendered individually for cash while the base policy continues untouched. This raises money without ending the contract and without a buyer. It reduces the total death benefit by the amount of additions surrendered. See settlement versus surrendering paid-up additions.
- Reduced paid-up insurance. Stop paying entirely and convert the accumulated value into a smaller death benefit that is fully paid up forever. No further premiums, no medical review. On a mature contract this often leaves a substantial permanent benefit. See reduced paid-up insurance.
- Policy loan. Borrow against the cash value at a contractual rate with no credit check and no repayment schedule. Interest accrues against the policy and a loan allowed to grow beyond the cash value causes a lapse with the tax consequences described above, so it needs monitoring rather than neglect.
Ranked against a sale, these usually win on a healthy insured and usually lose on a significantly impaired one. That is the same crossover as before, viewed from a different angle.
The company, the regulator, and what to send
OneAmerica Financial is an Indianapolis-based mutual holding company group. Its principal insurer, American United Life Insurance Company, was founded in 1877 as the German Mutual Life Insurance Company of Indiana and took its present name in 1936 following a merger. The State Life Insurance Company, also Indiana-domiciled, writes the group’s care solutions line, and Pioneer Mutual Life Insurance Company of North Dakota affiliated with American United Life in 1997. In a separate transaction, Voya Financial acquired the group’s full-service retirement plan recordkeeping business, closing in January 2022; life insurance policies did not move, though retirement statements now come from a different company.
The domiciliary regulator is the Indiana Department of Insurance. Indiana’s viatical and life settlement provisions are codified at Indiana Code section 27-8-19.8, covering licensing of providers and brokers, disclosure obligations, written authorization before medical information is released, and a statutory rescission right. The transaction itself is governed by the law of the state where the policy owner lives, so verify your own state’s act and confirm licensure with your own insurance department before signing anything.
To get a real answer rather than a guess, gather five things: the policy cover page and schedule; the most recent in-force values statement showing base face amount, total death benefit, total cash surrender value and current dividend; the premium history or cost basis if available; a statement of any outstanding loan; and a current medication list with the names of treating physicians. With those, an experienced reviewer can tell you within a day or two which side of the crossover you are on.
Pine Lake Life Solutions does not purchase policies and is not licensed in every state. The free policy review is educational, and on this product it frequently concludes that surrendering, redirecting a dividend, or electing reduced paid-up coverage beats every other option. Send the policy cover page and call (305) 209-7183. If the contract turns out to be a flexible-premium chassis rather than whole life, see OneAmerica universal life policies.
Frequently Asked Questions
Why does surrender usually beat selling on whole life?
Two reasons work together. The premium is fixed and cannot be reduced by a buyer, so a buyer must fund the full contractual premium rather than a minimum, which lowers what it can pay. And your cash surrender value on a mature contract is high, which raises the bar any offer must clear. At long life expectancies those two forces close the gap entirely.
When can a sale beat surrendering?
When the insured’s life expectancy is short. At a five-year estimate, the death benefit is discounted over far fewer years and the buyer funds far fewer premiums, so the value can move well above the surrender value. The decision is therefore mostly a medical question. If the insured has a significant documented impairment, the comparison is genuinely open and worth running.
Why is my death benefit larger than the face amount on the schedule page?
Because dividends have been purchasing paid-up additions. Each annual dividend buys a small block of permanent, fully paid coverage that earns dividends of its own in later years, and the compounding over thirty or forty years is substantial. Request a current in-force values statement showing base face amount, total death benefit, total cash surrender value and the current dividend.
Are surrender proceeds and sale proceeds taxed the same way?
No. On a surrender, the gain is generally the amount received minus premiums paid and is generally ordinary income. On a sale, the 2017 tax act removed the requirement to reduce basis by cost of insurance charges, which can produce a smaller taxable gain than the earlier rules. Sales also trigger information reporting under section 6050Y. Take both to your own tax professional.
Can I raise cash without ending the policy?
Usually yes, in three ways. Surrender accumulated paid-up additions individually for cash while the base policy continues. Redirect the dividend to cover the premium, which frees the cash you were spending on it. Or borrow against the cash value at a contractual rate. Each has consequences, so ask the carrier to quantify the effect on death benefit before executing.
What if I can no longer afford the premium at all?
Ask about reduced paid-up insurance. It converts the accumulated cash value into a smaller death benefit that is fully paid up, with no further premiums ever due and no medical review required. On a mature participating contract it often leaves a substantial permanent benefit, and it is almost always better than letting the policy lapse by missing a payment.
Find out what your policy is worth — free, confidential, no obligation.
A 15-minute educational review covers your eligibility, every alternative, and a realistic view of what each path would net you.
Related Reading
- What Is Whole Life Insurance
- Surrender Vs Sell Policy
- Life Settlement Vs Surrendering Paid Up Additions
- What Is Cash Surrender Value
- Life Settlement Tax Basis Explained
- Are Life Settlement Proceeds Taxable
- What Is Reduced Paid Up Insurance
- Cash Surrender Value Vs Offer
- Sell My One America Universal Life Policy
Pine Lake Life Solutions does not purchase life insurance policies and does not provide legal, tax, or investment advice. Information provided is for educational purposes only. Eligibility for any option, including life settlements, is not guaranteed and depends on individual circumstances, policy terms, underwriting, and market conditions. Consult independent legal, tax, or financial professionals before making decisions regarding a life insurance policy.